Drug
LNK01001
LNK01001 is a pharmaceutical drug with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
3
75%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
3(75.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Recruiting1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 21 (25.0%)
Phase 33 (75.0%)
Trials by Status
completed250%
recruiting125%
active_not_recruiting125%
Recent Activity
2 active trials
Showing 4 of 4
completedphase_3
A Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis.
NCT06277245
active_not_recruitingphase_3
A Study of LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA)
NCT06276998
recruitingphase_3
A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis
NCT07237568
completedphase_2
A Study of LNK01001 Capsule in Patients With Ankylosing Spondylitis
NCT06085534
Clinical Trials (4)
Showing 4 of 4 trials
NCT06277245Phase 3
A Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis.
NCT06276998Phase 3
A Study of LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA)
NCT07237568Phase 3
A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis
NCT06085534Phase 2
A Study of LNK01001 Capsule in Patients With Ankylosing Spondylitis
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4